Comparison of Hematological Parameters Between Survivors and Non-Survivors COVID-19 Patients in Saudi Arabia

References

• World Health Organization. WHO coronavirus (COVID-19) dashboard. Available from: https://covid19.who.int/. Accessed December 23, 2022.
   Google Scholar
• Yu N, Li W, Kang Q, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020;20(5):559–564. doi:10.1016/S1473-3099(20)30176-6
   PubMed Web of Science ®Google Scholar
• Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020;382:2012–2022. doi:10.1056/NEJMoa2004500
   PubMed Web of Science ®Google Scholar
• Leticia de oliveira toledo S, Sousa Nogueira L, Das Gracas Carvalho M, Romana Alves Rios D, de Barros Pinheiro M. COVID-19: review and hematologic impact. Clin Chim Acta. 2020;510:170–176. doi:10.1016/j.cca.2020.07.016
   PubMed Web of Science ®Google Scholar
• Samprathi M, Jayashree M. Biomarkers in COVID-19: an Up-To-Date Review. Front Pediatr. 2020;8:607647. doi:10.3389/fped.2020.607647
   PubMed Web of Science ®Google Scholar
• Adab P, Haroon S, O’Hara ME, Jordan RE. Comorbidities and covid-19. BMJ. 2022;377:o1431. doi:10.1136/bmj.o1431
   PubMedGoogle Scholar
• Cataudella E, Giraffa CM, Di marca S, et al. Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia. J Am Geriatr Soc. 2017;65:1796–1801. doi:10.1111/jgs.14894
   PubMed Web of Science ®Google Scholar
• Merekoulias G, Alexopoulos EC, Belezos T, Panagiotopoulou E, Jelastopulu DM. Lymphocyte to monocyte ratio as a screening tool for influenza. PLoS Curr. 2010;2:RRN1154. doi:10.1371/currents.rrn1154
   PubMedGoogle Scholar
• Angelidi AM, Belanger MJ, Mantzoros CS. Commentary: COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next. Metabolism. 2020;107:154245. doi:10.1016/j.metabol.2020.154245
   PubMed Web of Science ®Google Scholar
• Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751–753. doi:10.1001/jamacardio.2020.1105
   PubMed Web of Science ®Google Scholar
• Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818. doi:10.1001/jamacardio.2020.1017
   PubMed Web of Science ®Google Scholar
• Kanne JP. Chest CT findings in 2019 Novel coronavirus (2019-nCoV) infections from Wuhan, china: key points for the radiologist. Radiology. 2020;295(1):16–17. doi:10.1148/radiol.2020200241
   PubMed Web of Science ®Google Scholar
• Mehraeen E, Karimi A, Barzegary A, et al. Predictors of mortality in patients with COVID-19–a systematic review. Eur J Integr Med. 2020;40:101226. doi:10.1016/j.eujim.2020.101226
   PubMed Web of Science ®Google Scholar
• Tian W, Jiang W, Yao J, et al. Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis. J Med Virol. 2020;92(10):1875–1883. doi:10.1002/jmv.26050
   PubMed Web of Science ®Google Scholar
• Mesas AE, Cavero-Redondo I, Alvarez-Bueno C, et al. Predictors of in-hospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions. PLoS One. 2020;15(11):e0241742. doi:10.1371/journal.pone.0241742
   PubMed Web of Science ®Google Scholar
• General Authority for Statistics. Demography in Saudi Arabia; 2020. Available from: https://www.stats.gov.sa/sites/default/files/Population%20by%20Age%20Groups%20%2Cand%20Gender_0.pdf. Accessed December 24, 2022.
   Google Scholar
• General Authority for Statistics. General authority for statistics demographic survey. population by age groups, and gender mid year 2019. Available from: https://www.stats.gov.sa/sites/default/files/population_by_age_groups_and_gender_ar.pdf. Accessed December 24, 2022.
   Google Scholar
• Alamdari NM, Afaghi S, Rahimi FS, et al. Mortality risk factors among hospitalized COVID-19 patients in a major referral center in Iran. Tohoku J Exp Med. 2020;252(1):73–84. doi:10.1620/tjem.252.73
   PubMed Web of Science ®Google Scholar
• Doganci S, Ince ME, Ors N, et al. A new COVID-19 prediction scoring model for in-hospital mortality: experiences from Turkey, single center retrospective cohort analysis. Eur Rev Med Pharmacol Sci. 2020;24(19):10247–10257. doi:10.26355/eurrev_202010_23249
   PubMed Web of Science ®Google Scholar
• Sherwani S, Raafat M, Rajendrasozhan S, et al. Increased levels of autoantibodies against ROS-modified proteins in depressed individuals with decrease in antibodies against SARS-CoV-2 antigen (S1-RBD). Curr Issues Mol Biol. 2022;44(11):5260–5276. doi:10.3390/cimb44110358
   PubMed Web of Science ®Google Scholar
• Wilson JM, Lee J, Fitzgerald HN, Oosterhoff B, Sevi B, Shook NJ. Job insecurity and financial concern during the COVID-19 pandemic are associated with worse mental health. J Occup Environ Med. 2020;62(9):686–691. doi:10.1097/JOM.0000000000001962
   PubMed Web of Science ®Google Scholar
• Alyami MH, Naser AY, Orabi MAA, Alwafi H, Alyami HS. Epidemiology of COVID-19 in the Kingdom of Saudi Arabia: an ecological study. Front Public Health. 2020;8:506. doi:10.3389/fpubh.2020.00506
   PubMed Web of Science ®Google Scholar
• Birkmeyer JD, Barnato A, Birkmeyer N, Bessler R, Skinner J. The impact of the COVID-19 pandemic on hospital admissions in the United States. Health Aff. 2020;39(11):2010–2017. doi:10.1377/hlthaff.2020.00980
   PubMed Web of Science ®Google Scholar
• Kim Y, Gandhi RT. COVID-19: management in hospitalized adults. Available from: https://www.uptodate.com/contents/covid-19-management-in-hospitalized-adults. Accessed November 12, 2022.
   Google Scholar
• Alharthy A, Aletreby W, Faqihi F, et al. Clinical characteristics and predictors of 28-day mortality in 352 critically ill patients with COVID-19: a retrospective study. J Epidemiol Glob Health. 2020;11(1):98–104. doi:10.2991/jegh.k.200928.001
   PubMed Web of Science ®Google Scholar
• Baena-Diez JM, Barroso M, Cordeiro-Coelho SI, Diaz JL, Grau M. Impact of COVID-19 outbreak by income: hitting hardest the most deprived. J Public Health. 2020;42(4):698–703. doi:10.1093/pubmed/fdaa136
   Google Scholar
• Grasselli G, Zangrillo A, Zanella A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574–1581. doi:10.1001/jama.2020.5394
   PubMed Web of Science ®Google Scholar
• Vila-Corcoles A, Satue-Gracia E, Vila-Rovira A, de Diego-Cabanes C, Forcadell-Peris MJ, Ochoa-Gondar O. Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings. Aten Primaria. 2021;53(9):102118. doi:10.1016/j.aprim.2021.102118
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Z. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak. BMC Infect Dis. 2021;21(1):113. doi:10.1186/s12879-021-05814-4
   PubMed Web of Science ®Google Scholar
• Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/j.ijid.2020.03.017
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol. 2021;100:309–320. doi:10.1007/s00277-020-04366-y
   PubMed Web of Science ®Google Scholar
• Bellmann-Weiler R, Lanser L, Barket R, et al. Prevalence and predictive value of anemia and dysregulated iron homeostasis in patients with COVID-19 infection. J Clin Med. 2020;9. doi:10.3390/jcm9082429
   PubMed Web of Science ®Google Scholar
• Bouchla A, Kriebardis AG, Georgatzakou HT, et al. Red blood cell abnormalities as the mirror of SARS-CoV-2 disease severity: a pilot study. Front Physiol. 2021;12:825055. doi:10.3389/fphys.2021.825055
   PubMed Web of Science ®Google Scholar
• Bateman RM, Sharpe MD, Singer M, Ellis CG. The effect of sepsis on the erythrocyte. Int J Mol Sci. 2017;18. doi:10.3390/ijms18091932
   PubMed Web of Science ®Google Scholar
• Lam LKM, Reilly JP, Rux AH, et al. Erythrocytes identify complement activation in patients with COVID-19. Am J Physiol Lung Cell Mol Physiol. 2021;321:L485–L489. doi:10.1152/ajplung.00231.2021
   PubMed Web of Science ®Google Scholar
• Long H, Nie L, Xiang X, et al. D-dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis. Biomed Res Int. 2020;2020:6159720. doi:10.1155/2020/6159720
   PubMed Web of Science ®Google Scholar
• Gu X, Sha L, Zhang S, Shen D, Zhao W, Yi Y. Neutrophils and lymphocytes can help distinguish asymptomatic COVID-19 from moderate COVID-19. Front Cell Infect Microbiol. 2021;11:654272. doi:10.3389/fcimb.2021.654272
   PubMed Web of Science ®Google Scholar
• Kaushal K, Kaur H, Sarma P, et al. Serum ferritin as a predictive biomarker in COVID-19. A systematic review, meta-analysis and meta-regression analysis. J Crit Care. 2022;67:172–181. doi:10.1016/j.jcrc.2021.09.023
   PubMed Web of Science ®Google Scholar
• Sherwani S, Khan MWA. Cytokine response in SARS-CoV-2 infection in the elderly. J Inflamm Res. 2020;13:737–747. doi:10.2147/JIR.S276091
   PubMed Web of Science ®Google Scholar